MediFind found 15 doctor with experience in Polymorphous Low Grade Adenocarcinoma near Kansas City, KS. Of these, 10 are Experienced and 5 are Advanced.
University Of Kansas Hospital Authority
Prakash Neupane is a Hematologist Oncology specialist and a Hematologist in Kansas City, Kansas. Dr. Neupane is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Neupane is currently accepting new patients.
Kansas University Physicians Inc
Justin Bond is an Otolaryngologist in Kansas City, Kansas. Dr. Bond has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Facial Paralysis, Recurrent Peripheral Facial Palsy, Bell's Palsy, Laryngectomy, and Thyroidectomy. Dr. Bond is currently accepting new patients.
Kansas University Physicians Inc
Kiran Kakarala is an Otolaryngologist in Kansas City, Kansas. Dr. Kakarala is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Oral Squamous Cell Carcinoma, Laryngeal Cancer, Throat Cancer, Gastrostomy, and Laryngectomy. Dr. Kakarala is currently accepting new patients.
Kansas University Physicians Inc
Andres Bur is an Otolaryngologist in Kansas City, Kansas. Dr. Bur is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Tongue Cancer, Oral Squamous Cell Carcinoma, Adenoid Cystic Carcinoma, Glossectomy, and Thyroidectomy. Dr. Bur is currently accepting new patients.
Kansas University Physicians Inc
Yelizaveta Shnayder is a Plastic Surgeon and an Otolaryngologist in Kansas City, Kansas. Dr. Shnayder is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Oral Squamous Cell Carcinoma, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, Gastrostomy, and Laryngectomy. Dr. Shnayder is currently accepting new patients.
University Of Kansas Hospital Authority
David Ernst is a Hematologist Oncology specialist and a Hematologist in Kansas City, Missouri. Dr. Ernst is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Pancreatic Cancer, and Small Cell Lung Cancer (SCLC). Dr. Ernst is currently accepting new patients.
University Of Kansas Hospital Authority
Melisa Boersma is a Radiation Oncologist in Kansas City, Kansas. Dr. Boersma is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Angiosarcoma, and Liposarcoma. Dr. Boersma is currently accepting new patients.
Kansas University Physicians Inc
Daniel Keleti is a Radiation Oncologist in Kansas City, Kansas. Dr. Keleti is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Angiosarcoma. Dr. Keleti is currently accepting new patients.
Kansas University Physicians Inc
Erin Buczek is an Otolaryngologist and a Plastic Surgeon in Kansas City, Kansas. Dr. Buczek is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Tissue Biopsy. Dr. Buczek is currently accepting new patients.
Meritas Health Corporation
Matthew Mallory is a Radiation Oncologist in North Kansas City, Missouri. Dr. Mallory is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. Dr. Mallory is currently accepting new patients.
Ascentist Management
Nicholas Wirtz is an Otolaryngologist in Merriam, Kansas. Dr. Wirtz is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Mouth Ulcers, Mouth Sores, Acinic Cell Carcinoma of Salivary Glands, Glossectomy, and Thyroidectomy. Dr. Wirtz is currently accepting new patients.
University Of Kansas Hospital Authority
Gregory Crane is a Hematologist and an Oncologist in Overland Park, Kansas. Dr. Crane is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Breast Cancer, Melanoma of the Eye, Metastatic Uveal Melanoma, and Paget Disease of the Breast.
Kansas City Urology Care PA
James Coster is a Radiation Oncologist in Independence, Missouri. Dr. Coster is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, and Metastatic Uveal Melanoma. Dr. Coster is currently accepting new patients.
Kansas City Urology Care PA
Kenon Qamar is a Radiation Oncologist in Independence, Missouri. Dr. Qamar is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Qamar is currently accepting new patients.
Midwest Oncology Associates LLC
Anis Toumeh is an Oncologist in Overland Park, Kansas. Dr. Toumeh is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Chronic Lymphocytic Leukemia (CLL), and Pleuropulmonary Blastoma. Dr. Toumeh is currently accepting new patients.
Last Updated: 01/09/2026